Versant Capital Management, Inc Neogenomics Inc Transaction History

Versant Capital Management, Inc

$710 Million
Q3 2025

A detailed history of Versant Capital Management, Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Versant Capital Management, Inc holds 1,708 shares of NEO stock, worth $16,550. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,708

Previous 699 144.35%

Holding current value

$16,550

Previous $5,000 160.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	BUY	$4.84 - $8.81 $4,883 - $8,889	1,009 Added 144.35%	1,708 $13,000
Q2 2025 Jul 07, 2025	SELL	$6.4 - $10.27 $10,284 - $16,503	-1,607 Reduced 69.69%	699 $5,000
Q1 2025 Apr 03, 2025	BUY	$9.09 - $18.61 $4,644 - $9,509	511 Added 28.47%	2,306 $22,000
Q4 2024 Jan 02, 2025	BUY	$13.0 - $18.43 $14,846 - $21,047	1,142 Added 174.89%	1,795 $29,000
Q2 2024 Jul 05, 2024	SELL	$13.01 - $15.77 $5,620 - $6,812	-432 Reduced 39.82%	653 $9,000
Q1 2024 Apr 03, 2024	SELL	$14.06 - $16.79 $871 - $1,040	-62 Reduced 5.41%	1,085 $17,000
Q4 2023 Jan 08, 2024	BUY	$11.67 - $20.73 $6,430 - $11,422	551 Added 92.45%	1,147 $18,000
Q3 2023 Oct 11, 2023	SELL	$12.15 - $17.85 $5,589 - $8,211	-460 Reduced 43.56%	596 $7,000
Q2 2023 Jul 10, 2023	SELL	$14.1 - $19.83 $9,503 - $13,365	-674 Reduced 38.96%	1,056 $16,000
Q1 2023 Apr 10, 2023	BUY	$9.09 - $19.45 $10,598 - $22,678	1,166 Added 206.74%	1,730 $30,000
Q4 2022 Jan 25, 2023	SELL	$6.45 - $12.07 $1,206 - $2,257	-187 Reduced 24.9%	564 $0
Q3 2022 Dec 30, 2022	BUY	$7.86 - $12.91 $943 - $1,549	120 Added 19.02%	751 $6,000
Q2 2022 Aug 02, 2022	BUY	$7.06 - $13.97 $1,913 - $3,785	271 Added 75.28%	631 $5,000
Q1 2022 Apr 29, 2022	BUY	$12.15 - $35.28 $4,374 - $12,700	360 New	360 $4,000

Others Institutions Holding NEO

# of Institutions

308

Shares Held

127M

Call Options Held

1.17M

Put Options Held

297K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.22B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Account

Versant Capital Management, Inc Neogenomics Inc Transaction History